Wave Life Sciences Ltd. ($WVE)
Filing Information
| Accession Number | 0001193125-26-047323 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
322,963
Total Value
$48,258.60
P&L
+inf% (+$3,755,850.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Ordinary Shares | โ | Feb 5, 2026 | Grant/Award | 45,625 | $0.00 | $0.00 | 137,973 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Feb 9, 2026 | Sale | 3,588 | $13.45 | $48,258.60 | 134,385 | Direct | โ | View Details | |
Chief Financial Officer | Share Option (right to buy) | Derivative | Feb 5, 2026 | Grant/Award | 273,750 | $0.00 | $0.00 | 273,750 | Direct | โ | View Details |